D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients

Clinical trial NCT05734560 · RECRUITING

Trial details

NCT number: NCT05734560
Sponsor: Darell Bigner
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Newly Diagnosed MGMT Unmethylated Glioblastoma

Start date: 2023-09-06
Primary completion: 2026-10-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.